Bristol-Myers Gives Up on Hepatitis C Combination in U.S. (2)
Alert: HALISTER Source: BN (Bloomberg News)
Tickers BMY US (Bristol-Myers Squibb Co) ABBV US (AbbVie Inc) GILD US (Gilead Sciences Inc)
People John Boris (SunTrust Robinson Humphrey Capital Markets) Mark Schoenebaum (International Strategy & Investment Group LLC)
Topics Viral Hepatitis Cancers
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283